Radiopharmaceuticals in prostate cancer - PSMA Theranostics episode 2

Episode 2 May 12, 2021 00:21:48
Radiopharmaceuticals in prostate cancer - PSMA Theranostics episode 2
COR2ED Medical Education
Radiopharmaceuticals in prostate cancer - PSMA Theranostics episode 2

May 12 2021 | 00:21:48

/

Show Notes

Dr. Tanya Dorff (City of Hope Comprehensive Cancer Center, Los Angeles, USA) and Dr. Phillip Koo (Banner MD Anderson Cancer Center, Arizona, USA) discuss the latest developments in the field of radiopharmaceuticals and their use in Prostate Cancer.

This second episode focuses on PSMA-targeted radiopharmaceuticals and how PSMA can be a target for imaging as well as for therapies. Efficacy and safety data from the phase 2 TheraP study are discussed which investigated lutetium-PSMA versus cabazitaxel in patients with mCRPC who had progressed on docetaxel. The experts also discuss the ongoing VISION trial and what the results may mean for clinical practice as well as other ongoing trials looking at lutetium-PSMA in combination with other prostate cancer therapies such as PARP inhibitors, immunotherapies, hormonal therapies and chemotherapy. Treatment sequencing is also considered in terms of where lutetium-PSMA fits into clinical practice for mCRPC patients and how the treatment compares to Radium-223.

Other Episodes

Episode 12

April 26, 2023 00:21:09
Episode Cover

Treatment sequencing in advanced mCRC patients

COR2ED Medical Education: This podcast episode discusses treatment sequencing in advanced metastatic colorectal cancer (mCRC) patients, third line and beyond.  Dr Shubham Pant from...

Listen

Episode 1

August 02, 2022 00:24:06
Episode Cover

Changing paradigms of haemophilia care in Europe

Changing paradigms of haemophilia care in Europe COR2ED Medical Education: In this podcast, Prof. Cedric Hermans and Prof. Jerzy Windyga discuss their perspectives on...

Listen

Episode 2

October 21, 2021 00:24:56
Episode Cover

Choosing the Best Treatment Regimen in Multiple Myeloma: Episode 2 – the Relapsed/Refractory Setting

In this medical education podcast series, myeloma experts Dr. Karthik Ramasamy (Haematologist and Associate Professor of Haematology at the Oxford University Hospitals in London,...

Listen